CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia
| Autor: | Bielicka, I, Dickerson, S, Manamley, N, Das, A, Sandison, T |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S35-S35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect